Loading…
Bausch Health Companies Inc. is projected to rise to $6.19 by 2027, a +15% move from its current price of $5.39. BHC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.30 | $5.39 | $5.49 | +0.02% |
| May 30 | $5.26 | $5.39 | $5.53 | +0.04% |
| May 31 | $5.23 | $5.39 | $5.56 | +0.06% |
| Jun 1 | $5.20 | $5.39 | $5.59 | +0.08% |
| Jun 2 | $5.18 | $5.40 | $5.62 | +0.10% |
| Jun 3 | $5.16 | $5.40 | $5.64 | +0.12% |
| Jun 4 | $5.15 | $5.40 | $5.66 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.15 | $5.40 | $5.66 | +0.15% |
| Week 2 | $5.05 | $5.41 | $5.78 | +0.29% |
| Week 3 | $4.99 | $5.41 | $5.88 | +0.44% |
| Week 4 | $4.93 | $5.42 | $5.96 | +0.58% |
| Week 5 | $4.88 | $5.43 | $6.04 | +0.73% |
| Week 6 | $4.84 | $5.44 | $6.11 | +0.88% |
| Week 7 | $4.80 | $5.45 | $6.17 | +1.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. It sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc.
and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Bausch Health Companies Inc. (BHC) is a healthcare stock with a current price of $5.47 and a market cap of $2.04B. It is ranked 1991 by market capitalization among listed entities.
The stock sits within the Healthcare category and carries exposure to a broad pharmaceutical and medical devices portfolio. The near-term price outlook is informed by a multi-year forecast showing gradual gains, with higher targets later in the period. Forecasts map out a path from a 2026 average near $5.47 toward substantially higher levels by 2040 and 2050.
A major floor 8.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.9% away) — a key level to hold.
The nearest ceiling, 9.6% above — a clean break opens room to run.
A major ceiling 29.5% above — clearing it would confirm fresh momentum.
Key BHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.44 | Sell | $5.42 | Sell |
| MA 10 | $5.40 | Sell | $5.43 | Sell |
| MA 20 | $5.50 | Sell | $5.47 | Sell |
| MA 50 | $5.45 | Sell | $5.56 | Sell |
| MA 100 | $5.82 | Sell | $5.76 | Sell |
| MA 200 | $6.30 | Sell | $6.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.44 | Neutral |
| Stoch RSI (14) | 33.88 | Neutral |
| CCI (20) | -61.42 | Neutral |
| Williams %R (14) | -78.26 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.26 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 21.74 | Neutral |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 43.82 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 5.44 | Sell |
| ADX (14) | 10.10 | Neutral |
| ATR (14) | 0.09 | Info |
Market sentiment remains NEUTRAL. The RSI (14) is 50, indicating a neutral momentum stance.
The technical setup shows a SMA50 of $5.44 and a SMA200 of $6.30. Support sits at $5.29 and resistance at $5.91. The 30-day price range spans from a low of $4.83 to a high of $6.19.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.96 | $5.39 | $7.28 | 0% | Neutral | |
| $5.06 | $6.19 | $7.93 | +15% | Neutral | |
| $5.44 | $6.78 | $8.92 | +26% | Bullish | |
| $5.30 | $6.71 | $9.01 | +25% | Bullish | |
| $5.39 | $6.91 | $9.43 | +28% | Bullish | |
| $6.42 | $8.33 | $11.56 | +55% | Bullish | |
| $7.10 | $9.32 | $13.11 | +73% | Bullish | |
| $7.38 | $9.79 | $13.94 | +82% | Bullish | |
| $7.65 | $10.25 | $14.77 | +90% | Bullish | |
| $7.73 | $10.45 | $15.23 | +94% | Bullish | |
| $10.73 | $15.12 | $23.09 | +181% | Bullish | |
| $19.63 | $29.67 | $48.55 | +450% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.96 | $5.39 | $6.30 | +0.00% |
| June 2026 | $4.60 | $5.36 | $6.38 | -0.49% |
| July 2026 | $4.68 | $5.49 | $6.59 | +2.41% |
| August 2026 | $4.77 | $5.62 | $6.79 | +2.30% |
| September 2026 | $4.71 | $5.57 | $6.77 | -0.95% |
| October 2026 | $4.70 | $5.58 | $6.83 | +0.30% |
| November 2026 | $4.86 | $5.78 | $7.11 | +3.59% |
| December 2026 | $4.94 | $5.90 | $7.28 | +2.05% |
Click any year to see its month-by-month BHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Bausch Health Companies Inc.'s 2026 outlook centres on $5.39, within a $4.96 to $7.28 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BHC could reach as high as $7.93, with a base case around $6.19 and support toward $5.06 — roughly +15% from $5.39. A consolidation phase looks the most probable path here.
Expect BHC to range from $5.44 to $8.92 through 2028. The $6.78 average target implies a +26% move from current prices. That is up +10% on the projected 2027 average. Momentum favours further upside here.
The BHC price prediction for 2029 points to an average of $6.71 (low $5.30, high $9.01) — a potential gain of +25% on today's $5.39. Buyers look set to stay in control over this stretch.
In 2030, BHC is projected to trade between $5.39 and $9.43, averaging $6.91 — a potential gain of +28% from today's $5.39. That is up +3% on the projected 2029 average. Momentum favours further upside here.
Bausch Health Companies Inc.'s 2031 outlook centres on $8.33, within a $6.42 to $11.56 range. That is up +21% on the projected 2030 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BHC could reach as high as $13.11, with a base case around $9.32 and support toward $7.10 — roughly +73% from $5.39. Momentum favours further upside here.
Expect BHC to range from $7.38 to $13.94 through 2033. The $9.79 average target implies a +82% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BHC price prediction for 2034 points to an average of $10.25 (low $7.65, high $14.77) — a potential gain of +90% on today's $5.39. Momentum favours further upside here.
In 2035, BHC is projected to trade between $7.73 and $15.23, averaging $10.45 — a potential gain of +94% from today's $5.39. That is up +2% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Bausch Health Companies Inc.'s 2040 outlook centres on $15.12, within a $10.73 to $23.09 range. That is up +45% on the projected 2035 average. That marks a +181% change versus current levels. Momentum favours further upside here.
By 2050, BHC could reach as high as $48.55, with a base case around $29.67 and support toward $19.63 — roughly +450% from $5.39. Buyers look set to stay in control over this stretch.
Investing $1,000 in BHC today (≈ 185.528757 BHC) could be worth
$5,504.62
+$4,504.62 (+450%) by 2050 · US Dollar
Based on the average projected BHC price of $29.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHCwould be worth at today's price.
$1,000 invested in BHC on May 27, 2025 (≈ 217.864917 BHC) would be worth
$1,174.29
+$174.29 (+17.4%) today · 1.17× · US Dollar
Based on a BHC entry price of $4.59 vs. today's $5.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.5 | $980 | -2.0% |
| 1 month ago | $5.58 | $965.95 | -3.4% |
| 3 months ago | $6.04 | $892.38 | -10.8% |
| 6 months ago | $6.35 | $848.82 | -15.1% |
| 1 year ago | $4.59 | $1,174.29 | +17.4% |
| All time (5.0y) ago | $32.03 | $168.28 | -83.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHC forecast.
Our base-case forecast reaches $11.00 around 2040.
Implied market cap at $11.00: $4.11B
The year-by-year forecast paints a bullish longer-term trajectory. For 2026 the average is $5.47, modestly flat, with sentiment NEUTRAL. From 2027 onward the forecast shifts higher, culminating in a 2030 average of $6.97 with a 27.4% ROI and a bullish sentiment.
Beyond 2030, the outlook remains bullish, climbing to a 2040 average of $15.15 with a 177% ROI and a bullish stance. The 2050 forecast projects an average of $29.52 and a 439.6% ROI, continuing the bullish trend. Across 2031–2035 the forecast shows continued upside, with averages from $8.44 to $10.44 and rising max values, all labeled BULLISH.
These figures are estimates and not guarantees. They illustrate potential upside paths and are subject to market and company-specific risks that can cause actual results to differ significantly.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $6.97 with a min of $5.43 and a max of $9.52, and a 27.4% ROI. The sentiment is BULLISH.
The forecast indicates a bullish sentiment from 2028 onward, with the average price rising to $6.87 in 2028, $29.52 as the 2050 average, and a 439.6% ROI by 2050. These are estimates and not guarantees.
Yes. The 2031 forecast lists a min of $6.50, an average of $8.44, and a max of $11.71, with a 54.2% ROI and bullish sentiment.
Current price is $5.47. The 30-day range is $4.83 to $6.19.
2040: average $15.15, min $10.74, max $23.15, ROI 177, sentiment BULLISH. 2050: average $29.52, min $19.52, max $48.33, ROI 439.6, sentiment BULLISH.
Bausch Health Companies Inc. Community Discussion
0Share your Bausch Health Companies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.